| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | $5.5M+2.1% | $5.4M-14.9% | $6.4M+10.5% | $5.8M-5.4% | $6.1M |
| General and administrative | $4.0M+31.3% | $3.1M+20.7% | $2.6M+9.5% | $2.3M-11.4% | $2.6M |
| Total operating expenses | $9.6M+12.6% | $8.5M-4.8% | $8.9M+10.2% | $8.1M-7.2% | $8.7M |
| LOSS FROM OPERATIONS | -$9.6M-12.6% | -$8.5M+4.8% | -$8.9M-10.2% | -$8.1M+7.2% | -$8.7M |
| Interest income | $125K-54.1% | $272K-23.6% | $356K+2900.5% | $12K+26.9% | $9K |
| Interest expense | -$149+99.7% | -$50K-5210.0% | -$938+81.7% | -$5K+94.0% | -$85K |
| Other income (expense), net | $125K-43.8% | $222K-37.5% | $355K+5168.6% | $7K+108.6% | -$78K |
| NET LOSS | -$9.5M-14.1% | -$8.3M+3.4% | -$8.6M-5.9% | -$8.1M+8.1% | -$8.8M |
| Net loss per common share- basic | -$0.63+10.0% | -$0.70+5.4% | -$0.74-5.7% | -$0.70+13.6% | -$0.81 |
| Net loss per common share- diluted | -$0.63+10.0% | -$0.70+5.4% | -$0.74-5.7% | -$0.70+13.6% | -$0.81 |
| Weighted average common shares - basic | 15.1M+27.3% | 11.9M+2.1% | 11.6M+0.8% | 11.5M+5.8% | 10.9M |
| Weighted average common shares - diluted | 15.1M+27.3% | 11.9M+2.1% | 11.6M+0.8% | 11.5M+5.8% | 10.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.